Search results for "floppy iris syndrome"

showing 6 items of 6 documents

Cardiovascular and ocular safety of α1-adrenoceptor antagonists in the treatment of male lower urinary tract symptoms

2014

α1-Adrenoceptor antagonists (α-blockers) represent first-line drug treatment for male lower urinary tract symptoms. Their adverse events (AEs) include asthenia, dizziness, nasal congestion, arterial (orthostatic) hypotension and intraoperative floppy iris syndrome (IFIS).This report focuses on cardiovascular and ocular AEs of α-blockers as related to their mechanism of action and subtype selectivity.The incidence of hypotension differs between α-blockers. It is greatest with doxazosin or terazosin, but others including tamsulosin can also lead to hypotension especially upon treatment initiation. Concomitant antihypertensive medication increases the incidence of hypotension with some α-block…

MaleEye DiseasesIntraoperative floppy iris syndromeCataract ExtractionOrthostatic vital signsTerazosinLower Urinary Tract SymptomsPatient Education as TopicTamsulosinmedicineAnimalsHumansPharmacology (medical)Adverse effectAlfuzosinbusiness.industryGeneral MedicineSilodosinmedicine.diseaseBlood pressureCardiovascular DiseasesAnesthesiaAdrenergic alpha-1 Receptor AntagonistsFemalebusinessmedicine.drugExpert Opinion on Drug Safety
researchProduct

Pharmacologic pupil dilation as a predictive test for the risk for intraoperative floppy-iris syndrome.

2011

PURPOSE: To evaluate the effect of α1-adrenergic receptor antagonists (α1-ARAs) on pupil diameter and determine whether the diameter predicts intraoperative floppy-iris syndrome (IFIS). SETTING: Ophthalmology Section, Palermo University, Palermo, Italy. DESIGN: Prospective cohort study. METHODS: Male outpatients taking tamsulosin, α(1)-ARAs, or no α(1)-ARAs having phacoemulsification were recruited. Pupils were measured 1 month preoperatively, immediately preoperatively, and postoperatively under mesopic low (0.4 lux) and high (4.0 lux) illumination after pharmacologic dilation. The IFIS severity was graded. RESULTS: Each group comprised 50 patients. Pharmacologic dilation in both α(1)-ARA …

MaleTamsulosinmedicine.medical_specialtyMydriaticsmedicine.medical_treatmentIntraoperative floppy iris syndromeSensitivity and SpecificityPupilCohort StudiesPhenylephrineTropicamideTamsulosinPredictive Value of TestsRisk FactorsmedicinePupillary responseHumansProspective StudiesProspective cohort studyIntraoperative ComplicationsAgedSulfonamidesPhacoemulsificationbusiness.industrySettore MED/30 - Malattie Apparato VisivoDoxazosinfood and beveragesMuscle SmoothPupilPhacoemulsificationPrazosinSyndromebiochemical phenomena metabolism and nutritionmedicine.diseaseSensory SystemsSurgerycarbohydrates (lipids)OphthalmologyDrug CombinationsIfis pupil dilation tamsulosinIris DiseasesPredictive value of testsAdrenergic alpha-1 Receptor AntagonistsSurgerybusinessCohort studymedicine.drugJournal of cataract and refractive surgery
researchProduct

Determinants of inappropriate hospitalization in cataract surgery in the south of Italy: a retrospective study

2017

Purpose To analyze the frequency of inappropriate hospitalization in cataract surgery and the type of related determinants. Methods A nested retrospective case–control study was carried out on 2708 consecutive cataract surgery patients operated between January 2013 and Decem- ber 2015. All cases with inappropriate hospitalization (day surgery or ordinary hospitalization) were com- pared with a control group of cases treated in an appropriate (day service) regimen. The predictive value for inappropriate admissions to the hospital was assessed using a logistic regression model. Significant variables from the univariate analysis were included in a multivariate model. Results Forty-five cases (…

Malemedicine.medical_specialtyMultivariate analysismedicine.medical_treatmentOutpatient surgeryIntraoperative floppy iris syndromeCataract ExtractionLogistic regressionHealth Services MisuseSurgical appropriateness Hospitalization appropriateness Cataract surgery Comorbidities and hospital appropriatenessSettore MED/42 - Igiene Generale E Applicata03 medical and health sciences0302 clinical medicineRisk FactorsmedicineHumansAgedRetrospective StudiesAged 80 and overUnivariate analysisbusiness.industryRetrospective cohort studyCataract surgeryLength of StayMiddle Agedmedicine.diseaseHospitalizationOphthalmologyRegimenLogistic ModelsItalyCase-Control StudiesEmergency medicine030221 ophthalmology & optometryFemalebusiness030217 neurology & neurosurgery
researchProduct

dilatazione pupillare farmacologica come test predittivo del rischio di IFIS.

2013

Settore MED/30 - Malattie Apparato Visivofloppy iris syndromepredittività rischio IFIS dilatazione pupillare
researchProduct

uso degli alfa-bloccanti nell'ipertrofia prostatica benigna: il problema della "floppy iris syndrome". Risultati di uno studio caso-controllo per la …

2009

-

alfa-bloccanti ipertrofia prostatica benignaDIAMETRO PUPILLAREIPERTROFIA PROSTATICAALFABLOCCANTISettore MED/30 - Malattie Apparato Visivofloppy iris syndrome
researchProduct

Role of  1-Adrenoceptor Subtypes in Pupil Dilation Studied With Gene-Targeted Mice

2014

PURPOSE The α₁A-adrenoceptor (α₁A-AR) subtype was suggested to mediate contraction and trophic effects in the iris dilator muscle, and thus its pharmacological blockade may be involved in intraoperative floppy iris syndrome. We tested the hypothesis that the α₁A-AR mediates pupil dilation and trophic effects in the mouse iris. METHODS The α₁-AR subtype mRNA expression was quantified in iris tissue by real-time PCR. To assess the role of individual α₁-ARs for mediating pupil dilation, the α₁-AR agonist phenylephrine was topically applied to the ocular surface of mice deficient in one of the three α₁-AR subtypes (α₁A-AR(-/-), α₁B-AR(-/-), α₁D-AR(-/-), respectively) and wild-type controls. Cha…

medicine.medical_specialtyurogenital systemIntraoperative floppy iris syndromeAnatomyBiologymedicine.diseaseSensory SystemsPupilCellular and Molecular NeuroscienceOphthalmologyIris dilator muscleEndocrinologyAtrophyInternal medicinemedicinePupillary responseMydriasismedicine.symptomReceptorPhenylephrinemedicine.drugInvestigative Ophthalmology & Visual Science
researchProduct